突发利空！美医药股，大跌！

Market Overview - On August 25, US stock indices collectively declined, with the Dow Jones down 0.77%, S&P 500 down 0.43%, and Nasdaq down 0.22% [1] - Chinese concept stocks showed mixed performance, with the Nasdaq Golden Dragon China Index up 0.11% [1] Company-Specific Developments - Intel's stock fell by 1.01% after the company warned that the US government's 10% stake could pose risks to its business, potentially harming international sales and limiting future government subsidies [3] - Intel's international sales accounted for 76% of its total revenue in the last fiscal year [3] - The US government is set to become Intel's largest shareholder by purchasing 9.9% of its stock at a price lower than the current market value, which could dilute existing shareholders' equity [3] Pharmaceutical Sector Impact - President Trump announced plans to significantly reduce drug prices, aiming to cut them to 1/1400 to 1/1500 of current levels, which led to a decline in pharmaceutical stocks [5] - Following Trump's announcement, shares of DexCom fell over 7.6%, Moderna dropped 6.53%, Pfizer decreased by 2.86%, and Merck fell by 2.36% [5] Technology Sector Movements - Major tech stocks had mixed results, with Tesla up 1.94%, Google up 1.16%, and Nvidia up 1.02%, while Apple and Microsoft saw slight declines [5] - Nvidia announced the launch of its Jetson AGX Thor robotics chip module, which will be available for global customers, including those in China [5]